PBIO - Dividend announcements

Company's Largest Investor Exchanges First Seniority Debt into Non-Secured Equity at 38% Above-Market Price, Expressing Confidence and SupportSOUTH EASTON, MA / ACCESSWIRE / March 1, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a global leader in the development and sale of broadly enabling, high-pressure-based products and services to the life sciences and other industries, today announced that the Company's largest shareholder has exchanged over $10 million of senior secured debt into unsecured preferred stock. The debt being converted is comprised of convertible promissory notes, accrued and unpaid interest on all promissory notes issued to the investor since

Significant Growth Reported in Total Revenue (121%), Instrument Sales (235%), and Consumable Products (81%); Definitive Progress Continued in the BaroFold and UST Platforms; Closure Expected Soon on Agrochemical Supplier Asset AcquisitionInvestor Conference Call Scheduled for Wednesday, May 19, 2021 at 4:30 p.m. EDTSOUTH EASTON, MA / ACCESSWIRE / May 19, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food & beverage industries, today reported t